lamivudine has been researched along with at 61 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E | 1 |
| Conway, SC; King, RW; Ladner, SK; Miller, TJ; Otto, MJ; Perni, RB; Zaifert, K | 1 |
| Colledge, D; Delaney, WE; Edwards, R; Furman, P; Locarnini, S; Painter, G; Shaw, T | 1 |
3 other study(ies) available for lamivudine and at 61
| Article | Year |
|---|---|
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship | 2009 |
Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidine.
Topics: Amides; Antiviral Agents; Benzene Derivatives; Cell Line; Cell Survival; DNA, Viral; Drug Resistance, Microbial; Drug Synergism; Hepatitis B virus; Humans; Lamivudine; Nucleic Acid Synthesis Inhibitors; Ribonucleases; RNA-Directed DNA Polymerase; Tetracyclines; Transfection; Viral Plaque Assay; Virus Replication | 1998 |
Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro.
Topics: Amides; Anti-HIV Agents; Benzamides; Benzene Derivatives; Drug Resistance, Viral; Hepatitis B virus; Lamivudine; Viral Plaque Assay; Virus Replication | 2002 |